Research Division, Joslin Diabetes Center, Boston, MA.
Department of Pediatrics, Harvard Medical School, Boston, MA.
Am J Clin Nutr. 2019 Jul 1;110(1):111-120. doi: 10.1093/ajcn/nqy334.
Maternal obesity is a risk factor for childhood obesity; this is a major public health concern given that ∼40% of pregnant women are either overweight or obese. Whether differences in milk composition in lean compared with obese women contribute to childhood obesity is unclear.
We aimed to analyze relationships between maternal obesity and human milk metabolites, infant body composition, and postnatal weight gain.
This was a prospective study in which mothers intending to breastfeed exclusively, and their newborn infants, were enrolled at delivery (n = 35 mother-infant pairs). We excluded mothers with diabetes, other medical conditions, or pregnancy complications. Participants were grouped by maternal prepregnancy BMI <25 (lean) or ≥25 kg/m2 (overweight/obese). We analyzed infant body composition by dual-energy X-ray absorptiometry and used untargeted liquid chromatography-gas chromatography-mass spectrometry to measure the milk content of 275 metabolites at 1 and 6 mo postpartum.
At 1 mo postpartum, 10 metabolites differed between overweight/obese and lean groups with nominal P < 0.05, but none was altered with a false discovery rate <0.25. Many differentially abundant metabolites belonged to the same chemical class; e.g., 4/10 metabolites were nucleotide derivatives, and 3/10 were human milk oligosaccharides. Milk adenine correlated positively with both continuously distributed maternal BMI and with infant adiposity and fat accrual. Analysis of milk composition at 6 mo postpartum revealed 20 differentially abundant metabolites (P < 0.05) in overweight/obese compared with lean women, including 6 metabolites with a false discovery rate of <0.25. At both 1 and 6 mo, human milk abundance of 1,5-anhydroglucitol, which has not previously been described in milk, was positively associated with maternal BMI.
Maternal obesity is associated with changes in the human milk metabolome. While only a subset of metabolites correlated with both maternal and infant weight, these point to potential milk-dependent mechanisms for mother-child transmission of obesity. This trial was registered at www.clinicaltrials.gov as NCT02535637.
母体肥胖是儿童肥胖的一个风险因素;鉴于约 40%的孕妇超重或肥胖,这是一个主要的公共卫生关注点。在瘦体妇女与肥胖妇女相比,其乳汁成分的差异是否会导致儿童肥胖尚不清楚。
我们旨在分析母体肥胖与母乳代谢物、婴儿身体成分和产后体重增加之间的关系。
这是一项前瞻性研究,在分娩时纳入了打算纯母乳喂养的母亲及其新生儿(n=35 对母婴)。我们排除了患有糖尿病、其他疾病或妊娠并发症的母亲。根据母亲孕前 BMI<25(瘦)或≥25kg/m2(超重/肥胖)将参与者分组。我们通过双能 X 射线吸收法分析婴儿身体成分,并使用非靶向液相色谱-气相色谱-质谱法在产后 1 个月和 6 个月时测量 275 种代谢物的乳汁含量。
产后 1 个月时,275 种代谢物中有 10 种在超重/肥胖组和瘦体组之间存在差异(名义 P<0.05),但没有一种代谢物的差异在错误发现率<0.25 时仍然显著。许多差异丰度的代谢物属于同一化学类别;例如,10 种代谢物中有 4 种是核苷酸衍生物,3 种是人乳寡糖。母乳腺嘌呤与连续分布的母体 BMI 以及婴儿肥胖和脂肪积累呈正相关。在产后 6 个月时分析母乳成分,与瘦体妇女相比,超重/肥胖妇女的母乳中 20 种代谢物(P<0.05)差异显著,其中 6 种代谢物的错误发现率<0.25。在产后 1 个月和 6 个月时,母乳中 1,5-脱水葡萄糖醇的丰度与母体 BMI 呈正相关,1,5-脱水葡萄糖醇在母乳中以前没有被描述过。
母体肥胖与母乳代谢组的变化有关。虽然只有一部分代谢物与母亲和婴儿体重都相关,但这些代谢物提示了肥胖在母婴之间传递的潜在的依赖母乳的机制。本试验在 www.clinicaltrials.gov 上注册为 NCT02535637。